DONEPEZIL vs RIVASTIGMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DONEPEZIL vs RIVASTIGMINE: Safety Overview
| Metric | DONEPEZIL | RIVASTIGMINE |
|---|---|---|
| Total FAERS Reports | 8,834 | 9,123 |
| Deaths Reported | 1,101 | 2,232 |
| Death Rate | 12.5% | 24.5% |
| Hospitalizations | 3,963 | 2,716 |
| Average Patient Age | 77.2 yrs | 80.0 yrs |
| % Female Patients | 59.5% | 59.5% |
| FDA Approval Date | Apr 12, 2016 | Apr 21, 2000 |
| Manufacturer | A-S Medication Solutions | Novartis Pharmaceuticals Corporation |
| Route | ORAL | TRANSDERMAL |
| Marketing Status | Prescription | Discontinued |